EXCEED THE SPACE PROVIDED. Transgenic mouse models over-expressing APP develop senile plaques in an age-dependent fashion similar to those found in patients with Alzheimer's disease (AD). Recent evidence shows that active or passive immunotherapy dramatically prevents amyloid-13 deposition in transgenic mice. Clearance of existing amyloid-13 deposits present in Alzheimer's disease patients, in addition to prevention of new plaque formation, will be critical for an effective treatment. Observing senile plaques before and after treatment is the only direct way to measure clearance of existing deposits, but until recently this has not been possible. We have developed novel multiphoton microscopy techniques that allow longitudinal in vivo imaging of individual plaques. Using this approach, we demonstrated clearance of existing plaques in transgenic mice 3-5 days after a single application of antibodies to the cortex. In this application, we propose to test hypotheses about the mechanism of clearance.
Aim 1 follows from our observation that clearance can also occur with addition of F(ab')2 fragments, suggesting that Fc-mediated mechanisms are not necessary. We propose a model whereby clearance results from a two-step process involving disaggregation of amyloid-13 deposits via direct biophysical interaction followed by active removal of the amyloid.
Aim 2 asks whether systemic immunization, rather than topical application of antibody to cortex, will lead to clearance; if so, we will determine necessary titers and optimal epitopes.
Aim 3 takes advantage of in vitro results from several laboratories demonstrating that amyloid-13 binding compounds prevent or reverse formation of amyloid fibrils. We will test whether they are disaggregating agents in vivo. The results will strongly impact the development of treatments aimed at removing senile plaques and the associated neurological damage in Alzheimer's disease. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG020570-03
Application #
6837618
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Snyder, Stephen D
Project Start
2003-02-01
Project End
2007-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
3
Fiscal Year
2005
Total Cost
$287,613
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Garcia-Alloza, Monica; Borrelli, Laura A; Thyssen, Diana H et al. (2013) Four-dimensional microglia response to anti-A? treatment in APP/PS1xCX3CR1/GFP mice. Intravital 2:
Garcia-Alloza, Monica; Borrelli, Laura A; Hyman, Bradley T et al. (2010) Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice. Neurobiol Aging 31:2058-68
Coma, M; Sereno, L; Da Rocha-Souto, B et al. (2010) Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 38:482-91
Garcia-Alloza, Monica; Ferrara, Brian J; Dodwell, Sarah A et al. (2007) A limited role for microglia in antibody mediated plaque clearance in APP mice. Neurobiol Dis 28:286-92
Garcia-Alloza, M; Borrelli, L A; Rozkalne, A et al. (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095-104
Prada, Claudia M; Garcia-Alloza, Monica; Betensky, Rebecca A et al. (2007) Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci 27:1973-80
Robbins, Elissa M; Betensky, Rebecca A; Domnitz, Sarah B et al. (2006) Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci 26:365-71
Guo, Shuzhen; Wang, Sophia; Kim, Woo Jean et al. (2006) Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes. Brain Res 1111:222-6
Garcia-Alloza, Monica; Dodwell, Sarah A; Meyer-Luehmann, Melanie et al. (2006) Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 65:1082-9
Garcia-Alloza, Monica; Robbins, Elissa M; Zhang-Nunes, Sandy X et al. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516-24

Showing the most recent 10 out of 18 publications